VDR polymorphism, gene expression and vitamin D levels in leprosy patients from North Indian population I Singh, M Lavania, VK Pathak, M Ahuja, RP Turankar, V Singh, ... PLoS neglected tropical diseases 12 (11), e0006823, 2018 | 37 | 2018 |
Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients M Lavania, I Singh, RP Turankar, M Ahuja, V Pathak, U Sengupta, L Das, ... Journal of global antimicrobial resistance 12, 214-219, 2018 | 28 | 2018 |
Addition of Mycobacterium indicus pranii vaccine as an immunotherapeutic to standard chemotherapy in borderline leprosy: a double-blind study to assess clinical improvement … R Kamal, V Pathak, A Kumari, M Natrajan, K Katoch, HK Kar British Journal of Dermatology 176 (5), 2017 | 23 | 2017 |
Utility of multiplex PCR for early diagnosis and household contact surveillance for leprosy VK Pathak, I Singh, RP Turankar, M Lavania, M Ahuja, V Singh, ... Diagnostic microbiology and infectious disease 95 (3), 114855, 2019 | 19 | 2019 |
Association of non-tuberculous mycobacteria with Mycobacterium leprae in environment of leprosy endemic regions in India RP Turankar, V Singh, H Gupta, VK Pathak, M Ahuja, I Singh, M Lavania, ... Infection, Genetics and Evolution 72, 191-198, 2019 | 11 | 2019 |
Autoimmunity to Tropomyosin-Specific Peptides Induced by Mycobacterium leprae in Leprosy Patients: Identification of Mimicking Proteins I Singh, AR Yadav, KK Mohanty, K Katoch, P Sharma, VK Pathak, D Bisht, ... Frontiers in Immunology 9, 642, 2018 | 10 | 2018 |
Enriched whole genome sequencing identified compensatory mutations in the RNA polymerase gene of rifampicin-resistant Mycobacterium leprae strains M Lavania, I Singh, RP Turankar, AK Gupta, M Ahuja, V Pathak, ... Infection and drug resistance, 169-175, 2018 | 8 | 2018 |
Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: A threat to effective secondary line treatment for rifampicin-resistant leprosy cases M Ahuja, VK Pathak Journal of Global Antimicrobial Resistance 30, 282-285, 2022 | 5 | 2022 |
Efficacy of fixed duration multidrug therapy for the treatment of multibacillary leprosy: A prospective observational study from Northern India I Singh, M Ahuja, M Lavania, VK Pathak, RP Turankar, V Singh, ... Indian Journal of Dermatology, Venereology and Leprology 89 (2), 226-232, 2023 | 3 | 2023 |
Mimicking B and T cell epitopes between Mycobacterium leprae and host as predictive biomarkers in type 1 reaction in leprosy VK Pathak, I Singh, SV Singh, U Sengupta Scientific Reports 11 (1), 24431, 2021 | 2 | 2021 |
Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin … M Lavania, J Darlong, I Singh, M Ahuja, RP Turankar, VK Pathak, ... Journal of global antimicrobial resistance 23, 275-277, 2020 | 2 | 2020 |
Relapse and Drug Resistance in Leprosy: Present Scenario and Critical Issues RP Turankar, M Lavania, I Singh, M Ahuja, VK Pathak, V Singh, ... Ind J Leprosy 90, 79-93, 2018 | 2 | 2018 |
Corroboration of cross-reactivity between Mycobacterium leprae and hosts’ salivary and cutaneous proteins: A hope for prognostic biomarkers for the pathogenesis of reactions in … VK Pathak, I Singh, SV Singh, U Sengupta Frontiers in Microbiology 13, 1075053, 2022 | 1 | 2022 |
Paucibacillary Leprosy: Reappraisal using Ziehl-Neelsen staining of slit skin smears and 16S rRNA Real Time Polymerase Chain Reaction of nasal swabs RP Turankar, M Lavania, I Singh, V Singh, M Ahuja, VK Pathak, ... Leprosy Review 89 (3), 272-279, 2018 | 1 | 2018 |
Unveiling the role of NK cells, NKT-like cells, and γδ cells in pathogenesis of type 1 reactions in leprosy VK Pathak, I Singh, B Sharma, RP Turankar, M Arora, SV Singh, ... Heliyon 10 (3), 2024 | | 2024 |
Genomic characterization of Mycobacterium lepromatosis from ENL patients from India I Singh, VK Pathak, M Lavania, M Ahuja, R Sharma, T Narang, S Jain, ... Infection, Genetics and Evolution 116, 105537, 2023 | | 2023 |